TwinBeech Capital’s Bio-Techne TECH Stock Holding History

TwinBeech Capital’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-56,400	Closed	-$2.95M	–	680
2026 Q1	$2.95M	Buy	+56,400	New	+$3.39M	0.31%	99
2024 Q3	–	Sell	-68,876	Closed	-$4.93M	–	885
2024 Q2	$4.93M	Sell	68,876 -16,610	-19%	-$1.22M	0.1%	232
2024 Q1	$6.02M	Buy	+85,486	New	+$6.12M	0.12%	186
2023 Q4	–	Sell	-50,448	Closed	-$3.43M	–	899
2023 Q3	$3.43M	Buy	+50,448	New	+$3.99M	0.07%	322
2023 Q2	–	Sell	-17,213	Closed	-$1.28M	–	852
2023 Q1	$1.28M	Buy	+17,213	New	+$1.33M	0.03%	426
2022 Q4	–	Sell	-65,304	Closed	-$4.64M	–	935
2022 Q3	$4.64M	Sell	65,304 -45,068	-41%	-$3.89M	0.12%	203
2022 Q2	$9.56M	Buy	+110,372	New	+$10.3M	0.43%	71
2020 Q4	–	Sell	-11,016	Closed	-$682K	–	608
2020 Q3	$682K	Buy	11,016 +4,644	+73%	+$302K	0.15%	213
2020 Q2	$421K	Buy	+6,372	New	+$382K	0.09%	256
2020 Q1	–	Sell	-16,008	Closed	-$878K	–	466
2019 Q4	$878K	Buy	+16,008	New	+$840K	0.25%	130

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

TwinBeech Capital's TECH Position: Q2 2026 in Review

TwinBeech Capital sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 56,400 shares — an estimated $2.95M sold.

TwinBeech Capital first reported a position in TECH in Q4 2019 and held it in 10 quarters. The position peaked at $9.56M in Q2 2022. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

TwinBeech Capital reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
TwinBeech Capital sold 56,400 Bio-Techne shares in Q2 2026, an estimated $2.95M.
TwinBeech Capital first reported a position in Bio-Techne in Q4 2019 and held it in 10 quarters.
TwinBeech Capital's Bio-Techne position peaked at $9.56M in Q2 2022.
593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on TwinBeech Capital's 13F filing for Q2 2026, filed 14 Aug 2026.